4//SEC Filing
Cheung Suping (Sue) 4
Accession 0001209191-22-008135
CIK 0001441693other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:33 PM ET
Size
8.1 KB
Accession
0001209191-22-008135
Insider Transaction Report
Form 4
Cheung Suping (Sue)
Chief Financial Officer
Transactions
- Award
Common Stock
2022-02-07$0.63/sh+65,064$41,127→ 65,064 total - Award
Stock Option (Right to Buy)
2022-02-07+185,555→ 185,555 totalExercise: $0.63From: 2022-03-07Exp: 2025-02-06→ Common Stock (185,555 underlying)
Footnotes (2)
- [F1]On February 7, the reporting person was granted 65,064 restricted stock units, which represent a contingent right to receive one share of Issuer's common stock. The restricted stock units vest pursuant to the Vesting Schedule (as defined in footnote (2)) and are delivered to the reporting person upon vesting.
- [F2]The awards vest in equal monthly installments over three years, subject to the recipient's continued employment by the Issuer through the applicable vesting date, provided that, in lieu of the terms of any change in control agreement in place between the Issuer and the reporting person, in the event that the reporting person resigns for Good Reason (as defined in the recipient's change in control agreement) or is terminated without Cause (as defined in recipient's change in control agreement) within twelve months of a Change in Control (as defined in recipient's change in control agreement), 50% of the unvested portion of the awards will become immediately vested (the "Vesting Schedule").
Documents
Issuer
MARRONE BIO INNOVATIONS INC
CIK 0001441693
Entity typeother
Related Parties
1- filerCIK 0001646279
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:33 PM ET
- Size
- 8.1 KB